We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Drugs Could Target a Specific Anti-Acne Gene

By Biotechdaily staff writers
Posted on 10 Mar 2008
Dermatological researchers have found that the anti-acne drug 13-cis retinoic acid (isotretinoin) works by increasing expression of a gene that mediates apoptosis of human sebaceous glands. More...
While isotretinoin is the most potent drug available for treatment of acne, its use is restricted because of many potential serious side effects.

Investigators at the Pennsylvania State University College of Medicine (Hershey) worked with cell cultures prepared from sebaceous gland tissue obtained from acne patients either before treatment or after one week of isotretinoin therapy.

They reported in the March 3, 2008, online edition of the Journal of Clinical Investigation that lipocalin 2 was among the genes most highly upregulated by isotretinoin. Lipocalin 2 encodes neutrophil gelatinase–associated lipocalin (NGAL), which functions in innate immune defense and induces apoptosis of murine B lymphocytes.

The authors suggested that in light of the potential severe side effects of isotretinoin treatment, agents that selectively induce NGAL expression in sebaceous glands might represent therapeutic alternatives to the use of isotretinoin to treat individuals with acne.


Related Links:
Pennsylvania State University College of Medicine

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Thyroid Test
Anti-Thyroid EIA Test
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.